Compare Novartis AG (NVS) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while iShares 1 3 Year Treasury Bond ETF trades at $81.91. The key difference: Novartis AG pays a 3.07% dividend while iShares 1 3 Year Treasury Bond ETF pays none, and Novartis AG is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| NVS | SHY | |
|---|---|---|
Market Cap | $295.37B | — |
Sector | Health | Fixed Income |
52-Week High | $168.62 | $83.18 |
52-Week Low | $119.31 | $81.77 |
Enterprise Value | $336.69B | — |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
